摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(piperazin-1-yl)-N-(1,2,3,4-tetrahydro-acridin-9-yl)acetamide

中文名称
——
中文别名
——
英文名称
2-(piperazin-1-yl)-N-(1,2,3,4-tetrahydro-acridin-9-yl)acetamide
英文别名
2-piperazin-1-yl-N-(1,2,3,4-tetrahydroacridin-9-yl)acetamide
2-(piperazin-1-yl)-N-(1,2,3,4-tetrahydro-acridin-9-yl)acetamide化学式
CAS
——
化学式
C19H24N4O
mdl
——
分子量
324.426
InChiKey
MWKCDNFJTHGYJQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    57.3
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    7-(6-bromohexyloxy)-4-methyl-2H-chromen-2-one2-(piperazin-1-yl)-N-(1,2,3,4-tetrahydro-acridin-9-yl)acetamidepotassium carbonate 作用下, 以 乙腈 为溶剂, 反应 8.0h, 以41%的产率得到2-(4-(6-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)hexyl)piperazin-1-yl)-N-(1,2,3,4-tetrahydroacridin-9-yl)acetamide
    参考文献:
    名称:
    Design, synthesis and evaluation of novel tacrine–coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease
    摘要:
    A series of tacrine-coumarin hybrids (8a-t) were designed, synthesized and evaluated as multifunctional cholinesterase (ChE) inhibitors against Alzheimer's disease (AD). The screening results showed that most of them exhibited a significant ability to inhibit ChE and self-induced,beta-amyloid (A beta) aggregation, and to act as metal chelators. Especially, 8f displayed the greatest ability to inhibit acetylcholinesterase (AChE, IC50 = 0.092 mu M) and A beta aggregation (67.8%, 20 mu M). It was also a good butyrylcholinesterase inhibitor (BuChE, IC50 = 0.234 mu M) and metal chelator. Besides, kinetic and molecular modeling studies indicated that 8f was a mixed-type inhibitor, binding simultaneously to active, peripheral and mid-gorge sites of AChE. These results suggested that 8f might be an excellent multifunctional agent for AD treatment. (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.03.051
  • 作为产物:
    描述:
    9-胺-1,2,3,4-四氢盐酸氯酯三乙胺 、 potassium iodide 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 3.0h, 生成 2-(piperazin-1-yl)-N-(1,2,3,4-tetrahydro-acridin-9-yl)acetamide
    参考文献:
    名称:
    作为抗阿尔茨海默病多功能候选药物的新型他克林-阿魏酸杂合体的设计、合成和评价
    摘要:
    合成了五种新型他克林-阿魏酸杂化化合物(8a-e),并在详细光谱分析的基础上鉴定了它们的结构。在体外评估了抑制乙酰胆碱酯酶 (AChE) 和丁酰胆碱酯酶 (BuChE)、减少自诱导 β-淀粉样蛋白 (Aβ) 聚集和螯合 Cu2+ 的活性。其中,8c 和 8d 在抑制 AChE 方面表现出比 BuChE 更高的选择性。此外,8d 还显示出对自身 Aβ 聚集、螯合 Cu2+ 的活性和对 Neuro-2A 细胞中 Aβ 诱导的神经毒性的活性的显着抑制。
    DOI:
    10.3390/molecules21101338
点击查看最新优质反应信息

文献信息

  • 一种他克林-8-羟(胺)基喹啉衍生物及其应用
    申请人:广东工业大学
    公开号:CN105367553A
    公开(公告)日:2016-03-02
    本发明涉及一种他克林-8-羟(胺)基喹啉衍生物及其应用,属于生物医药技术领域;该衍生物包括式I化合物及其药学上适用的盐;其制备方法是将化合物Id和Ii与中间体In/In’经还原胺化、脱保护得到化合物I,在醇溶液中可反应制备成盐;经药理试验证实该类化合物具有抗阿茨海默症活性,能够抑制乙酰胆碱酯酶和丁酰胆碱酯酶活性,同时能够抑制β-淀粉样蛋白的自聚合并对金属离子特别是Cu2+、Zn2+具有一定的螯合作用,从而起到延缓乙酰胆碱的水解和β-淀粉样蛋白的自聚合,提高乙酰胆碱在突触的作用,并调节脑内金属离子,可有效用于治疗阿茨海默症。
  • Design, synthesis and evaluation of novel tacrine–coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease
    作者:Sai-Sai Xie、Xiao-Bing Wang、Jiang-Yan Li、Lei Yang、Ling-Yi Kong
    DOI:10.1016/j.ejmech.2013.03.051
    日期:2013.6
    A series of tacrine-coumarin hybrids (8a-t) were designed, synthesized and evaluated as multifunctional cholinesterase (ChE) inhibitors against Alzheimer's disease (AD). The screening results showed that most of them exhibited a significant ability to inhibit ChE and self-induced,beta-amyloid (A beta) aggregation, and to act as metal chelators. Especially, 8f displayed the greatest ability to inhibit acetylcholinesterase (AChE, IC50 = 0.092 mu M) and A beta aggregation (67.8%, 20 mu M). It was also a good butyrylcholinesterase inhibitor (BuChE, IC50 = 0.234 mu M) and metal chelator. Besides, kinetic and molecular modeling studies indicated that 8f was a mixed-type inhibitor, binding simultaneously to active, peripheral and mid-gorge sites of AChE. These results suggested that 8f might be an excellent multifunctional agent for AD treatment. (C) 2013 Elsevier Masson SAS. All rights reserved.
  • Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer’s Disease
    作者:Yingbo Fu、Yu Mu、Hui Lei、Pu Wang、Xin Li、Qiao Leng、Li Han、Xiaodan Qu、Zhanyou Wang、Xueshi Huang
    DOI:10.3390/molecules21101338
    日期:——
    Five novel tacrine-ferulic acid hybrid compounds (8a–e) were synthesized and their structures were identified on the basis of a detailed spectroscopic analysis. The activities of inhibiting acetyl cholinesterase (AChE) and butyryl cholinesterase (BuChE), reducing self-induced β-amyloid (Aβ) aggregation and chelating Cu2+ were evaluated in vitro. Among them, 8c and 8d displayed the higher selectivity
    合成了五种新型他克林-阿魏酸杂化化合物(8a-e),并在详细光谱分析的基础上鉴定了它们的结构。在体外评估了抑制乙酰胆碱酯酶 (AChE) 和丁酰胆碱酯酶 (BuChE)、减少自诱导 β-淀粉样蛋白 (Aβ) 聚集和螯合 Cu2+ 的活性。其中,8c 和 8d 在抑制 AChE 方面表现出比 BuChE 更高的选择性。此外,8d 还显示出对自身 Aβ 聚集、螯合 Cu2+ 的活性和对 Neuro-2A 细胞中 Aβ 诱导的神经毒性的活性的显着抑制。
查看更多